
|Videos|May 23, 2014
Lung Cancer Research and the Stigma of Cigarette Smoking
Author(s)Gregory J. Riely, MD, PhD
Gregory J. Riely, MD, PhD, vice chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses the impact of the stigma of cigarette smoking on lung cancer research.
Advertisement
Clinical Pearls
Gregory J. Riely, MD, PhD, vice chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses the impact of the stigma of cigarette smoking on lung cancer research.
- Research into lung cancer has been somewhat hindered by the stigma of cigarette smoking.
- Some histologies of lung cancer are more tightly connected with cigarette smoking.
- Small cell and squamous cell tumors are the most tightly linked to cigarette smoking and have had the least funding for research.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































